News

AddToAny

Google+ Facebook Twitter Twitter

"HIV vaccine design shows promise"

A novel protein-sugar vaccine candidate has stimulated an immune response against sugars that form a protective shield around HIV.

It has been tested in an animal model and it is hoped that the molecule could one day become part of a successful HIV vaccine.

Lai-Xi Wang, one of the researchers working on the project, said: “An obstacle to creating an effective HIV vaccine is the difficulty of getting the immune system to generate antibodies against the sugar shield of multiple HIV strains. Our method addresses this problem by designing a vaccine component that mimics a protein-sugar part of this shield.”

The researchers, from the University of Maryland and Duke University, designed a vaccine candidate using an HIV protein fragment linked to a sugar group.

When injected into rabbits, the vaccine candidate stimulated antibody responses against the sugar shield in four different HIV strains.

bit.ly/BS_DecNews1

Related Articles

The new dawn of immunotherapy

Steven Rosenberg made headlines around the globe for a breakthrough that could make immunotherapy a frontline cancer treatment.

Vaccine to treat lung cancer

A first-of-its-kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

Journal-based learning: iStock

July: Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Could bacteriophages replace antibiotics?

A small-scale preliminary trial concludes that bacteriophages could be a viable replacement for antibiotics in the future.

Top